AA

Amruta Ashok Bhombe

Active Director Designated Partner DIN 07564180
DIN 07564180 First appointment Aug 2016 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Amruta Ashok Bhombe

Data last updated:

Amruta Ashok Bhombe is a Designated Partner at Process Biotech Llp (since 2016). The company operates in Biotechnology.

DIN 07564180
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 04 Aug 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Aug 20162016Active

Board colleagues of Amruta Ashok Bhombe

NameDINCompanyDesignation
Jaideep Abhay Tilak07564170Process Biotech LlpDesignated Partner
Pradeep Shankar Mundle01041484Process Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Process Biotech Llp
Premium access

Shareholding and investment profile for Amruta Ashok Bhombe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amruta Ashok Bhombe

Amruta Ashok Bhombe currently holds 1 directorship: Process Biotech Llp (Designated Partner, since 04 Aug 2016).

Amruta Ashok Bhombe was first appointed on 04 Aug 2016 as Designated Partner at Process Biotech Llp.

The current boards of Amruta Ashok Bhombe's companies include Jaideep Abhay Tilak (Process Biotech Llp), Pradeep Shankar Mundle (Process Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available